These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9591211)

  • 1. Stromal IGF-II messenger RNA in breast cancer: relationship with progesterone receptor expressed by malignant epithelial cells.
    Giani C; Pinchera A; Rasmussen A; Fierabracci P; Bonacci R; Campini D; Bevilacqua G; Trock B; Lippman ME; Cullen KJ
    J Endocrinol Invest; 1998 Mar; 21(3):160-5. PubMed ID: 9591211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant breast epithelium selects for insulin-like growth factor II expression in breast stroma: evidence for paracrine function.
    Singer C; Rasmussen A; Smith HS; Lippman ME; Lynch HT; Cullen KJ
    Cancer Res; 1995 Jun; 55(11):2448-54. PubMed ID: 7757999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGF-II mRNA and protein are expressed in the stroma of invasive breast cancers: an in situ hybridization and immunohistochemistry study.
    Giani C; Cullen KJ; Campani D; Rasmussen A
    Breast Cancer Res Treat; 1996; 41(1):43-50. PubMed ID: 8932875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor (IGF)-I, IGF-II and IGF type I receptor (IGFR-I) expression in prostatic cancer.
    Cardillo MR; Monti S; Di Silverio F; Gentile V; Sciarra F; Toscano V
    Anticancer Res; 2003; 23(5A):3825-35. PubMed ID: 14666684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor II (IGF-II) immunohistochemistry in breast cancer: relationship with the most important morphological and biochemical prognostic parameters.
    Giani C; Campani D; Rasmussen A; Fierabracci P; Miccoli P; Bevilacqua G; Pinchera A; Cullen KJ
    Int J Biol Markers; 2002; 17(2):90-5. PubMed ID: 12113587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer.
    Henriksen KL; Rasmussen BB; Lykkesfeldt AE; Møller S; Ejlertsen B; Mouridsen HT
    Acta Oncol; 2009; 48(4):522-31. PubMed ID: 19173092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of progesterone on simultaneous, local secretion of IGFBP-3 and IGF-I [IGFBP-3/IGF-I index] by human malignant and non-malignant breast explants depends on tissue steroid receptor phenotype.
    Krzysiek J; Milewicz T; Augustowska K; Sztefko K; Ryś J; Zubel A; Pityński K; Jaszczyński P; Herman K; Basta A; Stachura J; Gregoraszczuk EŁ
    Ginekol Pol; 2003 Sep; 74(9):767-74. PubMed ID: 14674122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth factor messenger RNA expression by human breast fibroblasts from benign and malignant lesions.
    Cullen KJ; Smith HS; Hill S; Rosen N; Lippman ME
    Cancer Res; 1991 Sep; 51(18):4978-85. PubMed ID: 1893385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell kinetic study of the endometrium by nonisotopic in situ hybridization for histone H3 messenger RNA and immunohistochemistry for Ki-67 and for estrogen and progesterone receptors.
    Hayama M; Ota H; Toki T; Ishii K; Honda T; Momose M; Nakata R
    Anat Rec; 2002 Apr; 266(4):234-40. PubMed ID: 11920386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer.
    Cui X; Zhang P; Deng W; Oesterreich S; Lu Y; Mills GB; Lee AV
    Mol Endocrinol; 2003 Apr; 17(4):575-88. PubMed ID: 12554765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of estrogen and progesterone receptors in endometrium and peritoneal endometriosis: an immunohistochemical and in situ hybridization study.
    Fujishita A; Nakane PK; Koji T; Masuzaki H; Chavez RO; Yamabe T; Ishimaru T
    Fertil Steril; 1997 May; 67(5):856-64. PubMed ID: 9130890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The insulin-like growth factors, their receptors, and their binding proteins in human breast cancer.
    Yee D; Rosen N; Favoni RE; Cullen KJ
    Cancer Treat Res; 1991; 53():93-106. PubMed ID: 1672092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of Msx2 gene expression by steroid hormones in human nonmalignant and malignant breast cancer explants cultured in vitro.
    Malewski T; Milewicz T; Krzysiek J; Gregoraszczuk EL; Augustowska K
    Cancer Invest; 2005; 23(3):222-8. PubMed ID: 15945508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue.
    Chong YM; Colston K; Jiang WG; Sharma AK; Mokbel K
    Breast Cancer Res Treat; 2006 Oct; 99(3):275-88. PubMed ID: 16752221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor.
    Milewicz T; Kolodziejczyk J; Krzysiek J; Basta A; Sztefko K; Kurek S; Stachura J; Gregoraszczuk EL
    Gynecol Endocrinol; 2002 Aug; 16(4):319-29. PubMed ID: 12396561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid hormone receptor gene expression in human breast cancer cells: inverse relationship between oestrogen and glucocorticoid receptor messenger RNA levels.
    Hall RE; Lee CS; Alexander IE; Shine J; Clarke CL; Sutherland RL
    Int J Cancer; 1990 Dec; 46(6):1081-7. PubMed ID: 2249895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of IGF-I and IGF-II mRNA in breast tissue.
    Paik S
    Breast Cancer Res Treat; 1992; 22(1):31-8. PubMed ID: 1421422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression in breast cancer FNA cell blocks and paired histologic specimens: A large retrospective study.
    Vohra P; Buelow B; Chen YY; Serrano M; Vohra MS; Berry A; Ljung BM
    Cancer Cytopathol; 2016 Nov; 124(11):828-835. PubMed ID: 27315045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amount of stroma is associated with mammographic density and stromal expression of oestrogen receptor in normal breast tissues.
    Gabrielson M; Chiesa F; Paulsson J; Strell C; Behmer C; Rönnow K; Czene K; Östman A; Hall P
    Breast Cancer Res Treat; 2016 Jul; 158(2):253-61. PubMed ID: 27349429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct nuclear receptor expression in stroma adjacent to breast tumors.
    Knower KC; Chand AL; Eriksson N; Takagi K; Miki Y; Sasano H; Visvader JE; Lindeman GJ; Funder JW; Fuller PJ; Simpson ER; Tilley WD; Leedman PJ; Graham J; Muscat GE; Clarke CL; Clyne CD
    Breast Cancer Res Treat; 2013 Nov; 142(1):211-23. PubMed ID: 24122391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.